Effects of Erythropoietin for Cognitive Side-effects of ECT

Clinical trial NCT03339596 · COMPLETED

Trial details

NCT number: NCT03339596
Sponsor: Martin Balslev Jørgensen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ECT Cognitive Impairment Unipolar Depression Bipolar Depression

Start date: 2017-06-26
Primary completion: 2023-01-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.